The connectivity map of multi-drug combinations

The response to drug combinations critically depends on how their biological targets are connected, according to a study published online in Molecular Systems Biology this week. Understanding how multi-drug combinations work is vital in medicine, in order to rationalize their use and discover novel targets.

PRESS RELEASE FROM MOLECULAR SYSTEMS BIOLOGY
(<http://www.nature.com/msb/>)

This press release is copyrighted to the journal Molecular Systems Biology.

PLEASE CITE MOLECULAR SYSTEMS BIOLOGY AND THE MOLECULAR SYSTEMS BIOLOGY WEBSITE AS THE SOURCE OF THE FOLLOWING ITEM. IF PUBLISHING ONLINE, PLEASE CARRY A HYPERLINK TO www.nature.com/msb/ <http://www.nature.com/msb/>

The connectivity map of multi-drug combinations
DOI: 10.1038/msb4100116

The response to drug combinations critically depends on how their biological targets are connected, according to a study published online in Molecular Systems Biology this week. Understanding how multi-drug combinations work is vital in medicine, in order to rationalize their use and discover novel targets.

Joseph Lehár and colleagues analyzed the response of yeast and human tumour cell lines to thousands of drug pairs, and compared these experimental data to a computational model. By systematically measuring the biological effects of drug pairs over a range of concentrations, ‘response surfaces’ could be constructed. This strategy enabled the authors to establish a clear relationship between the shape of the biological ‘response surface’ and the type of connection linking the targeted biochemical pathways.

This study provides a general framework to analyze the effects of drug combinations and will help future researchers to better understand and develop effective multi-drug therapeutics.

Author contact:
Joseph Lehár (CombinatoRx Incorporated, Cambridge, MA, USA)
Tel: +1 617 301 7151; E-mail: [email protected]

Editorial contact:
Thomas Lemberger (Molecular Systems Biology, Germany)
Tel: +49 6221 8891 404; E-mail: [email protected]

Media contacts:
Helen Jamison (Nature London)
Tel: +44 20 7843 4658; E-mail: [email protected]

Ruth Francis (Nature London)
Tel: +44 20 7843 4562; E-mail: [email protected]

About Nature Publishing Group

Nature Publishing Group (NPG) is a division of Macmillan Publishers Ltd, dedicated to serving the academic, professional scientific and medical communities. NPG's flagship title, Nature, was first published in 1869. Other publications include Nature research journals, Nature Reviews, Nature Clinical Practice and a range of prestigious academic journals including society-owned publications. NPG also provides news content through [email protected] and scientific career information through Naturejobs.

NPG is a global company with headquarters in London and offices in New York, San Francisco, Washington DC, Boston, Tokyo, Paris, Munich, Hong Kong, Melbourne, Delhi, Mexico City and Basingstoke. For more information, please go to www.nature.com

Published: 27 Feb 2007

Contact details:

The Macmillan Building, 4 Crinan Street
London
N1 9XW
United Kingdom

+44 20 7833 4000
Country: 
Journal:
News topics: 
Content type: 
Websites: 

http://www.nature.com/msb/ MOLECULAR SYSTEMS BIOLOGY

Reference: 

MOLECULAR SYSTEMS BIOLOGY

Medicine